Abstract Objective To update the 2000 American Academy of Neurology (AAN) practice
parameter on anticonvulsant prophylaxis in patients with newly diagnosed brain tumors …

Purpose The extent of resection (EOR) is an independent prognostic factor for overall
survival (OS) in adult patients with Glioma Grade 4 (GG4). The aim of the neuro-oncology …

Background Levetiracetam is commonly used for seizure prophylaxis in patients with
intracerebral hemorrhage (ICH), traumatic brain injury (TBI), supratentorial neurosurgery …

Objective Antiepileptic treatment of brain tumor patients mainly depends on the individual
physician's choice rather than on well‐defined predictive factors. We investigated the …

Background The incidence of seizures in intensive care units ranges from 3.3% to 34%. It is
therefore often necessary to initiate or continue anticonvulsant drugs in this setting. When a …

Epilepsy in brain tumors (BTE) may require medical attention for a variety of unique
concerns: epileptic seizures, possible serious adverse effects of antineoplastic and …

Abstract Purpose of Review The relationship of brain tumors and seizures remains poorly
understood. This article is an overview of the epidemiology, etiology, and diagnostic and …

Aims The aim of this study was to perform an up‐to‐date systematic review and meta‐
analysis on the efficacy and safety of prophylactic administration of levetiracetam in brain …

Objective To identify risk factors for developing seizures pre-and postoperatively in low-and
high-grade gliomas. Patients and Methods 282 patients undergoing neurosurgical tumor …

Seizures are common complications for patients with brain tumors. No clear evidence exists
regarding the use of antiepileptic agents for prophylactic use yet newer agents are being …